TCL Archive Carcinogenesis Program Direction Changes Near for Extramural research; Workshop Topics Listed April 22, 1977
TCL Archive Dramatic responses to Iressa prompted further bench research. Results have limited clinical relevance, for now, but findings may explain failure of INTACT studies. April 30, 2004
TCL Archive Cancer Genetics Network approved By NCI Advisors, To Start With 8 Centers November 29, 1996
TCL Archive National Toxicology Program: Saccharin No Longer Listed as Carcinogen in NTP Report May 19, 2000
TCL Archive In Brief: Immunologists Boycott USSR Trip; Centers Program Staff Reorganized, Trimmed Down June 2, 1978
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
